Research
Adherence
Lifestyle interventions alone are difficult to maintain long-term for weight loss in patients with T2DM and CKD, whereas GLP-1 RAs offer a pharmacological alternative with proven metabolic and organ protection benefits.
While lifestyle changes are important, they are hard to keep up long-term. GLP-1 RAs can help you maintain weight loss and protect your heart and kidneys, making it easier to stick to healthy habits. Talk to your doctor about whether a GLP-1 RA is right for you.
GoodQualifiesHIGH confidence
However, the fundamental challenge of treating obesity solely with ‘lifestyle interventions’ is the difficulty of maintaining these changes over time.
Why this rating
Based on the Look AHEAD trial analysis and general clinical experience discussed in the review.
Source
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity
Daria Abasheva et al. · Clinical Kidney Journal · 2024
narrative_reviewCited 45×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →